Newsroom
Filters: Value added medicines
x
Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]
Read moreLegislative reforms aligned with current off-patent market conditions are the […]
Read more“EU Industry Welcomes New Schengen Strategy’s Green Lanes” Read more
READ MORE“Too much at stake in the EU pharma strategy to […]
Read moreThe newly launched update of the industrial strategy aims to […]
Read moreChristoph Stoller will speak at 3A CONFERENCE – Availability, Accessibility, […]
Read moreEU Pharma strategy provides unique moment to establish a regulatory […]
Read more